CN Patent

CN1829741A — 利用抗－vegf抗体的治疗

Assigned to Genentech Inc · Expires 2006-09-06 · 20y expired

What this patent protects

本发明总体涉及利用抗－VEGF抗体治疗疾病以及病理状况。更具体地，本发明涉及治疗利用抗－VEGF抗体易患或诊断为患有癌症的患者，优选与一或多种其它抗肿瘤治疗剂联用。

USPTO Abstract

本发明总体涉及利用抗－VEGF抗体治疗疾病以及病理状况。更具体地，本发明涉及治疗利用抗－VEGF抗体易患或诊断为患有癌症的患者，优选与一或多种其它抗肿瘤治疗剂联用。

Drugs covered by this patent

Patent Metadata

Patent number
CN1829741A
Jurisdiction
CN
Classification
—
Expires
2006-09-06
Drug substance claim
No
Drug product claim
No
Assignee
Genentech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.